Regeneron Pharmaceuticals, Inc. News - REGN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Regeneron Pharmaceuticals, Inc. REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -2.18 -0.71% 305.24 315.20 304.00 306.81 307.42 23:59:56
more quote information »

Recent News

Date Time Source Heading
6/14/201907:56DJNRegeneron Says Early-Stage Results Positive for REGN1979 in..
6/14/201907:00PRNUSRegeneron CD20xCD3 Bispecific REGN1979 Shows Positive..
5/29/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201909:30PRNUSRegeneron Announces Upcoming Investor Conference..
5/16/201907:00PRNUSUpdated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable..
5/15/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
5/14/201910:47EDGARConfidential Treatment Order (ct Order)
5/13/201916:19PRNUSFDA Approves EYLEA® (aflibercept) Injection for Diabetic..
5/13/201915:29DJNRegeneron Says FDA Approves Eylea Injection for All Diabetic..
5/13/201914:45PRNUSFDA Approves EYLEA® (aflibercept) Injection for Diabetic..
5/09/201916:52EDGARConfidential Treatment Order (ct Order)
5/07/201917:01EDGARAmended Current Report Filing (8-k/a)
5/07/201914:06EDGARConfidential Treatment Order (ct Order)
5/07/201909:39DJNEU Approves Sanofi and Regeneron's Dupixent for Severe..
5/07/201908:59PRNUSDupixent® (dupilumab) Approved for Severe Asthma by European..
5/07/201907:51EDGARQuarterly Report (10-q)
5/07/201907:36EDGARCurrent Report Filing (8-k)
5/07/201907:13DJNRegeneron's Expense Growth Weighs on Operating Income
5/07/201906:30PRNUSRegeneron Reports First Quarter 2019 Financial and Operating..
5/03/201916:03EDGARCurrent Report Filing (8-k)
4/29/201916:01PRNUSRegeneron Announces Upcoming Investor Conference..
4/26/201920:29DJNFDA Approves Expanded Label for Praluent
4/26/201919:19PRNUSFDA Approves Praluent® (alirocumab) to Prevent Heart Attack,..
4/26/201916:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/26/201916:11EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/26/201916:11EDGARProxy Statement (definitive) (def 14a)
4/26/201912:48DJNRegeneron, Sanofi Skin Cancer Drug Gets Warm Reception from..
4/26/201911:15PRNUSCHMP Issues Positive Opinion for Libtayo® (cemiplimab) in..
4/18/201919:05EDGARStatement of Changes in Beneficial Ownership (4)
4/10/201917:13EDGARCurrent Report Filing (8-k)
4/08/201916:01PRNUSRegeneron to Report First Quarter 2019 Financial and..
4/08/201907:00PRNUSRegeneron and Alnylam Announce Broad Collaboration to..
3/25/201907:40GLOBERecent Analysis Shows Mastercard, Halliburton, Keysight..
3/22/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
3/15/201916:01PRNUSPraluent® (alirocumab) now approved in European Union to..
3/13/201907:00PRNUSRegeneron and Sanofi to Present New Praluent® (alirocumab)..
3/12/201923:02PRNUSTeen Scientists Win $1.8 Million at Regeneron Science Talent..
3/12/201921:56PRNUSTeen Scientists Win $1.8 Million at Regeneron Science Talent..
3/12/201911:36PRNUSFDA Approves Dupixent® (dupilumab) for Moderate-to-severe..
3/11/201916:33DJNRegeneron Says FDA Approves Dupixent for Atopic Dermatitis..
3/11/201915:45PRNUSFDA approves Dupixent® (dupilumab) for moderate-to-severe..
3/11/201915:44PRNUSFDA Approves Dupixent® (dupilumab) for Moderate-to-severe..
3/11/201901:00PRNUSNew Genetic Data from Regeneron and GSK on 50,000 UK Biobank..
3/08/201916:01PRNUSRegeneron Announces Upcoming Investor Conference Call
3/08/201906:40DJNRegeneron, Sanofi Get FDA Priority Review for Dupixent
3/08/201900:59PRNUSFDA to Undertake Priority Review of Dupixent® (dupilumab)..
3/01/201908:35PRNUSCHMP Recommends Approval of Dupixent® (dupilumab) for Asthma..
3/01/201906:59PRNUSNew Analyses to Be Presented at AAD for Dupixent®..
2/25/201918:22DJNAmgen Says Delaware Jury Upholds Co's Patents On Repatha
2/25/201917:22PRNUSRegeneron and Sanofi Strongly Disagree with Verdict..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.